Lucian Constantin Mocan

Lucian Constantin Mocan

Auto-generated profile, based on publicly available information

Lucian Constantin Mocan


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2018 in Studia Universitatis Babeș-Bolyai Chemia
Verified
Journal Article
Open access
CMCristian Tudor Matea
Cristian Tudor Matea
TMTeodora Mocan
Teodora Mocan
FTFlaviu Tabaran
Flaviu Tabaran
TPTeodora Pop
Teodora Pop
OMOfelia Mosteanu
Ofelia Mosteanu
CZClaudiu-Dragoș Zdrehuș
Claudiu-Dragoș Zdrehuș
We have synthetized silver nanoparticles capped with: citrate, mercaptosuccinic acid, and thioctic acid, respectively. Each of the obtained nanoparticles were characterized by means of: UV-Vis and ATR-FT-IR spectroscopy, dynamic light scattering (DLS), atomic force microscopy (AFM) and were found to be spherical in shape and aqueous stable.

1 August 2026 in Academic Journal of Health Sciences
Verified
Journal Article
Open access
DCDănilă Cătălina
Dănilă Cătălina
LFLucian Faur
Lucian Faur
Laurean Ovidiu PopLaurean Ovidiu Pop
Laurean Ovidiu Pop
APAndrea Pop-Crisan
Andrea Pop-Crisan
LMLucian Mocan
Lucian Mocan
SIMONA CAVALUSIMONA CAVALU
SIMONA CAVALU
Background: H. pylori is known for its role in gastric carcinogenesis, but its potential association with colorectal neoplasia remains incompletely understood. Objective: We evaluated the relationship between H. pylori-associated inflammatory changes in histopathology and colorectal polyps in a symptomatic tertiary-care cohort. Methods: This cross-sectional study included 139 patients undergoing both gastroscopy and colonoscopy. Gastric and colonic biopsies were evaluated according to the updated Sydney System and WHO histopathologic criteria. Multivariate logistic regression analyses adjusted for age and gender were performed to explore associations between gastric pathology and colorectal neoplastic outcomes. Results: H. pylori-positive patients had a significantly higher prevalence of colorectal polyps compared to uninfected individuals (OR 5.98, 95% CI 2.68-13.35; p <0.001), and the association remained significant after age adjustment (adjusted OR 4.85, 95% CI 2.11-11.16, p <0.001). H. pylori infection was independently associated with colorectal adenomas (adjusted OR 3.31; 95% CI 1.22-9.00; p=0.019). Premalignant gastric changes, including atrophy and intestinal metaplasia, were associated with increased risk of colorectal polyps (OR 4.12; 95% CI 1.12–15.24; p = 0.036). Conclusions: H. pylori-associated gastric inflammatory and premalignant histopathological changes were associated with a higher prevalence of colorectal neoplastic lesions in this tertiary-care cohort. These findings support the hypothesis that cumulative gastric inflammatory burden may be linked to colorectal neoplasia, although larger prospective multicenter studies are required for validation.

29 September 2026 in Pharmacia
Verified
Journal Article
Open access
PDF file
DCDănilă Cătălina
Dănilă Cătălina
LFLucian Faur
Lucian Faur
LMLucian Mocan
Lucian Mocan
SIMONA CAVALUSIMONA CAVALU
SIMONA CAVALU
Objectives : The eradication of Helicobacter pylori is often challenged by antimicrobial resistance, adherence issues, and regional variation in treatment outcomes. As a hypothesis-generating step, early-stage pharmaceutical prioritization can identify repurposed or bioactive structures for experimental testing. This study compared the docking profiles of niclosamide and berberine against selected H. pylori enzymatic targets, using levofloxacin as a clinically relevant antibacterial comparator. Materials and methods : Blind molecular docking was performed against H. pylori urease, DNA gyrase subunit A, and shikimate kinase. Top-ranked poses were described using Vina-type scores, three-dimensional binding inspection, two-dimensional residue-interaction mapping, and absorption, distribution, metabolism, excretion, and toxicity (ADMET)/drug-likeness predictions. Docking scores were treated as ranking scores rather than binding free energies or experimental affinity constants. Results : In this small docking matrix, berberine produced the most negative descriptive mean score, while niclosamide produced one of the two top-ranked urease poses. These score differences do not establish differences in binding affinity, target engagement, or biological potency. Levofloxacin was included as a clinically relevant comparator. Predicted ADMET descriptors highlighted compound-specific questions related to exposure, solubility, and formulation but were not interpreted as evidence of therapeutic suitability. Conclusion : The integrated analysis prioritizes niclosamide and berberine for further anti- H. pylori investigation without demonstrating binding, enzyme inhibition, antibacterial activity, or therapeutic efficacy. The predicted poses and scores, considered alongside existing experimental literature and predicted ADMET descriptors, define testable hypotheses for urease inhibition assays, minimum inhibitory concentration (MIC) determination, cytotoxicity testing, and formulation-focused studies.

28 September 2018 in Studia Universitatis Babeș-Bolyai Chemia
Verified
Journal Article
Open access
CMCristian Tudor Matea
Cristian Tudor Matea
TMTeodora Mocan
Teodora Mocan
FTFlaviu Tabaran
Flaviu Tabaran
TPTeodora Pop
Teodora Pop
OMOfelia Mosteanu
Ofelia Mosteanu
CZClaudiu-Dragoș Zdrehuș
Claudiu-Dragoș Zdrehuș
Gold nanoparticles have been functionalized with the biologically active MUC-1 peptide conjugated to KLH and the obtained bio-nanostructure was characterized using an array of techniques such as: UV-Vis and ATR-FT-IR spectroscopy, dynamic light scattering (DLS) and atomic force microscopy (AFM). A 54 nm monodisperse bio-nanostructure with high aqueous stability was obtained.